Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
Dapagliflozin combined with Metformin is a fixed-dose pharmaceutical formulation for type 2 diabetes management. The synthesis involves coupling SGLT2 inhibitor Dapagliflozin Propanediol with biguanide Metformin Hydrochloride. Molecular formula: C18H29NO7·C4H11N5O4; CAS No.: 1044614-14-9 (salt complex).
Contraindicated in severe renal impairment or metabolic acidosis. Store in cool, dry conditions below 25°C to prevent hydrolysis. Strict adherence to GMP standards required during API handling.